Skip to content

Automated Left Ventricular Function Evaluation by LVivoEF

Automated Left Ventricular Function Evaluation by LVivoEF

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01515267
Acronym
LVivoEF
Enrollment
100
Registered
2012-01-24
Start date
2011-11-30
Completion date
Unknown
Last updated
2012-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biplane EF Evaluation, EF Evaluation From 2 Chamber Plane, EF Evaluation From 4 Chamber Plane, Left Ventricular Function

Keywords

EF, EDV, ESV, Biplane, Echocardiography

Brief summary

Left ventricular ejection fraction (EF) is evaluated in every echocardiographic examination either by visual estimation (eyeballing) requiring high level of training and expertise and/or by manual tracing of the endocard from which EF is calculated (manual biplane method (MBP)). This procedure is subjective and time consuming. The objective of this study is to compare the performance of LVivoEF software system to the measurements obtained by the routinely used methods.

Detailed description

LVivoEF is a decision support system (software) for automated global left ventricle (LV) systolic function evaluation from echocardiographic examinations. LVivoEF technology is based on a novel image processing algorithm for LV edge detection and ejection fraction (EF) evaluation. LVivoEF provides fully automated measurements of the left ventricle (LV) from two apical views the four chamber (4CH) and the two chamber (2CH).

Interventions

None listed

Sponsors

DiA Imaging Analysis Ltd
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age \> 18 * Patients referred to an echocardiographic examination. The patients will be consecutive until 30% of patients with normal LV function are enrolled. After that only consecutive patients with abnormal LV function will be included.

Exclusion criteria

* Examinations in which more than one third of the endocard is not visible in a plane (2CH/4CH) * Patients with Left bundle branch block (LBBB)

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026